Non melanoma skin cancer pathogenesis overview

D Didona, G Paolino, U Bottoni, C Cantisani - Biomedicines, 2018 - mdpi.com
(1) Background: Non-melanoma skin cancer is the most frequently diagnosed cancer in
humans. The process of skin carcinogenesis is still not fully understood. However, several …

The role of DLLs in cancer: a novel therapeutic target

MX Xiu, YM Liu, B Kuang - OncoTargets and therapy, 2020 - Taylor & Francis
Delta-like ligands (DLLs) control Notch signaling. DLL1, DLL3 and DLL4 are frequently
deregulated in cancer and influence tumor growth, the tumor vasculature and tumor …

Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients

I Sullivan, P Riera, M Andrés, A Altés, M Majem… - Angiogenesis, 2019 - Springer
Introduction Clinical and pathological characteristics are still considered prognostic markers
in metastatic non-small-cell lung cancer (NSCLC) patients but they cannot explain all …

Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy

YJ Kim, WC Chung, KH Jun, HM Chin - BMC cancer, 2019 - Springer
Background The relationship between polymorphisms in vascular endothelial growth factor
(VEGF) and gastric cancer is still inconclusive. We investigated whether there is an …

Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α–VEGF-induced angiogenesis of non-small cell lung cancer via the AKT pathway

L Qi, F Zhu, S Li, L Si, L Hu, H Tian - PloS one, 2014 - journals.plos.org
Background Pathological angiogenesis plays an essential role in tumor aggressiveness and
leads to unfavorable prognosis. The aim of this study is to detect the potential role of …

Transcriptional regulation of the VEGF gene in dependence of individual genomic variations

CS Metzger, D Koutsimpelas, J Brieger - Cytokine, 2015 - Elsevier
Overexpression of the vascular endothelial growth factor (VEGF) gene has been associated
with advanced stage and poor survival in several cancers. The majority of disease …

CXC chemokine ligand 4 (CXCL4) is predictor of tumour angiogenic activity and prognostic biomarker in non-small cell lung cancer (NSCLC) patients undergoing …

A Spaks, D Svirina, I Spaka, I Jaunalksne, D Breiva… - Biomarkers, 2016 - Taylor & Francis
Objective: To evaluate the association of CXC chemokine ligand 4 (CXCL4) plasma levels
with tumour angiogenesis in non-small cell lung cancer (NSCLC) and to assess association …

[HTML][HTML] Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma

Z Tie, R Bai, Z Zhai, G Zhang, H Zhang… - … journal of clinical and …, 2014 - ncbi.nlm.nih.gov
We aimed to assess whether the five common SNPs can affect the risk of osteosarcoma, and
its association with demographic characteristics of osteosarcoma. 165 osteosarcoma …

Impact of VEGF Gene Polymorphisms in Elderly Cancer Patients: Clinical Outcome and Toxicity

D Della-Morte, S Riondino, P Ferroni… - …, 2015 - Taylor & Francis
Vascular endothelial growth factors (VEGFs) are the key regulators in angiogenesis and
have been shown to play a significant role in the progression and prognosis of angiogenesis …

Hedgehog/Gli1 signal pathway facilitates proliferation, invasion, and migration of cutaneous SCC through regulating VEGF

Q Sun, J Bai, R Lv - Tumor Biology, 2016 - Springer
Abstract Since hedgehog (HH)/Gli1 that contributes to cancer proliferation and metastasis
has been masked for decades, the signaling pathway was investigated about its exact role …